Jump to content

User talk:Oeryc

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 12 hours ago by MediaWiki message delivery in topic ArbCom 2026 Elections voter message

Your submission at Articles for creation: Di-β-phenylisopropylamine has been accepted

[edit]
Di-β-phenylisopropylamine, which you submitted to Articles for creation, has been accepted!

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.

Future articles

Next steps

Thanks again, and happy editing!

Sulfurboy (talk) 17:33, 14 August 2026 (UTC)Reply

Your submission at Articles for creation: Thymus quinquecostatus (August 16)

[edit]
Draft declined
Thank you for contributing to Wikipedia. Your draft submission to Articles for creation has been reviewed but not accepted because it included copyrighted content, which is not permitted on Wikipedia.
This draft appears to contain copyrighted material from https://www.worldfloraonline.org/taxon/wfo-0000324646, which has been removed. Wikipedia strictly prohibits copyright violations. Assume all text is copyrighted unless released under a compatible license. Users who continue to post copyrighted material may be blocked from editing Wikipedia.

Scam warning

Sulfurboy (talk) 19:07, 16 August 2026 (UTC)Reply
Teahouse logo
Hello, Oeryc!

Having a draft declined at Articles for creation can be disappointing, but don't be discouraged, it's common when creating your first article.

Need help?

  • To understand why your draft was declined, please read the reviewer's feedback and follow any links to help pages you've been given. If you're still confused, try asking for advice at the Articles for creation Help desk.

Your submission at Articles for creation: Thymus quinquecostatus has been accepted

[edit]
Thymus quinquecostatus, which you submitted to Articles for creation, has been accepted!

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.

Future articles

Next steps

Thanks again, and happy editing!

Sulfurboy (talk) 19:21, 16 August 2026 (UTC)Reply

Welcome, Oeryc!

[edit]
A plate of chocolate chip cookies on a blue and white striped plate. The plate sits on a beige surface.
Have a plate of cookies!

Welcome to Wikipedia, Oeryc! I'm User:The person who loves reading, and I've been assigned as your mentor. All new Wikipedia accounts receive a mentor chosen randomly from a list of volunteers. It just means I'm here to help with anything you need! We need to have all kinds of people working together to create an online encyclopedia, so I'm glad you're here. Over time, you will figure out what you enjoy doing the most on Wikipedia.

You might have noticed that you have access to a tutorial and suggested edits. It's recommended that you take advantage of this, as it'll make learning how to edit Wikipedia easier.

If you need assistance with anything or have any questions, click on the "Get editing help" button on the bottom right corner of your screen. This will open up a module with links to help pages and a place to ask me questions. You can also ask me questions directly on my talk page, or go here to get help from the wider community.

Again, welcome to Wikipedia! The person who loves reading (talk) 23:10, 17 August 2026 (UTC)Reply

Your submission at Articles for creation: Vicadrostat has been accepted

[edit]
Vicadrostat, which you submitted to Articles for creation, has been accepted!

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.

Future articles

Next steps

Thanks again, and happy editing!

Shocksingularity (talk) 03:02, 19 August 2026 (UTC)Reply

Your submission at Articles for creation: Hemi-flyscaline has been accepted

[edit]
Hemi-flyscaline, which you submitted to Articles for creation, has been accepted!

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.

Future articles

Next steps

Thanks again, and happy editing!

Graeme Bartlett (talk) 22:06, 20 August 2026 (UTC)Reply

CS1 error on 2C-T-14

[edit]

Hello, I'm Qwerfjkl (bot). I have automatically detected that this edit performed by you, on the page 2C-T-14, may have introduced referencing errors. They are as follows:

  • A bare URL and missing title error. References show this error when they do not have a title. Please edit the article to add the appropriate title parameter to the reference. (Fix | Ask for help). Below are the references causing this error:
    • isomerdesign.com https://isomerdesign.com/pihkal/read/pk/46#2082. Retrieved 2026-09-05. {{cite web}}: Missing or empty |title= (help)
    • isomerdesign.com https://isomerdesign.com/pihkal/read/pk/12#2082. Retrieved 2026-09-05. {{cite web}}: Missing or empty |title= (help)

Please check this page and fix the errors highlighted. If you think this is a false positive, you can report it to my operator. Thanks, Qwerfjkl (bot) (talk) 18:27, 5 September 2026 (UTC)Reply

N-Benzylphenethylamines moved to draftspace

[edit]

Thanks for your contributions to N-Benzylphenethylamines. Unfortunately, I do not think it is ready for publishing as a live article at this time because it has no sources. I have converted it to a draft which you can improve, undisturbed for a while.

Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit the draft for review!" button at the top of the page OR move the page back. John B123 (talk) 21:33, 9 September 2026 (UTC)Reply

[edit]

Hi. Thank you for your recent edits. An automated process has detected that when you recently edited GAMMA (drug), a link pointing to the disambiguation page Oral was added. Such links are usually incorrect, since a disambiguation page is merely a list of unrelated topics with similar titles. (Read the FAQ • Join us at the DPL WikiProject.)

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, --DPL bot (talk) 17:59, 10 September 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on 2C-T-14. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Rather borderline notability, given that it's entirely dependent on Shuglin. A merge or redirect to 2C (psychedelics)#List of 2C drugs, where it is tabulated, might be a better solution unless more can be found to expand the article.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 09:40, 20 September 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on Di-β-phenylisopropylamine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thanks for this very interesting, focussed article on a drug sometimes confused with amphetamine. It is clearly structured and appropriately referenced. It's from a large class of compounds, but has sufficient notability for separate coverage.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 18:51, 21 September 2026 (UTC)Reply

Trihydroxyphenethylamine moved to draftspace

[edit]

An article you recently created, Trihydroxyphenethylamine, is not suitable as written to remain published. It needs more citations from reliable, independent sources. (?) Information that can't be referenced should be removed (verifiability is of central importance on Wikipedia). I've moved your draft to draftspace (with a prefix of "Draft:" before the article title) where you can incubate the article with minimal disruption. When you feel the article meets Wikipedia's general notability guideline and thus is ready for mainspace, please click on the "Submit your draft for review!" button at the top of the page. Dan arndt (talk) 03:12, 22 September 2026 (UTC)Reply

List of Amanita species known to contain psychoactive compounds moved to draftspace

[edit]

Thanks for your contributions to List of Amanita species known to contain psychoactive compounds. Unfortunately, I do not think it is ready for publishing as a live article at this time because it has no sources. I have converted it to a draft which you can improve, undisturbed for a while.

Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit the draft for review!" button at the top of the page OR move the page back. -MPGuy2824 (talk) 06:16, 3 October 2026 (UTC)Reply

New cross-language page link: Tetramethoxyallylbenzene

[edit]

A new page 6-甲氧基榄香素 on the Chinese Wikipedia has been linked to the page Tetramethoxyallylbenzene, which you created, via Wikidata (Q27138694).

You will not be notified about future links to pages you created. To opt in to these notifications, follow the opt-in instructions.

NervousBot (talk) 10:11, 16 October 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on Meta-Hydroxyephedrine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thanks for creating this page for a compound with a rather long history. It is part of a large class of compounds with similar action. It is well integrated into the family of monoamine reuptake inhibitors. From here, it would be helpful to add further sources, initially to confirm its notability, and then to build content.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 09:25, 17 October 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on 4-Bromo-α-pyrrolidinopentiophenone. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thanks for creating this article on a substituted cathinone. There is an argument for consolidating the set of compounds, given that there are so many of them with similar pharmacology. However, it seems reasonable for now to keep this article. Linking it from other articles would be helpful, and that might be most easily done by adding it to the monoamine reuptake inhibitors template.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 13:50, 17 October 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on Calycanthine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

What a great article; thanks for creating it. While it's no longer an orphan, it might be helpful to link it from a few other places.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 10:44, 18 October 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on RTI-6037-13. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thank you for creating this article on a chemical compound. It seems reasonable to keep for now, although I wonder whether a collective page for cathinones with similar properties might be better in the long term in order to avoid overlap. It would also be helpful to source this article from authors other than Carroll et al., in order to better establish notability.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 10:51, 18 October 2026 (UTC)Reply

I have sent you a note about a page you started

[edit]

Hi Oeryc. Thank you for your work on 6-Aminodopamine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thank you for another interesting article; the comparison to 6-hydroxydopamine was certainly helpful to me (that compound perhaps being better know in my corner of pharmacology). Clear and appropriately referenced.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 10:54, 18 October 2026 (UTC)Reply

PAV-0056 moved to draftspace

[edit]

Thanks for your contributions to PAV-0056. Unfortunately, I do not think it is ready for publishing as a live article at this time because it needs more sources to establish notability. I have converted it to a draft which you can improve, undisturbed for a while.

Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit the draft for review!" button at the top of the page OR move the page back. Klbrain (talk) 10:56, 18 October 2026 (UTC)Reply

Tools for chemistry articles

[edit]

Hi UseR:Oeryc,

I notice you've been creating a lot of chemistry articles, both individual chemicals and classes or groups. Are you using any tools to help with formatting or content organization, or to help decide what links to add? DMacks (talk) 12:53, 25 October 2026 (UTC)Reply

November 2026

[edit]

Copyright problem icon Your edit to Amaryllidaceae alkaloid has been removed in whole or in part because it contained copyrighted material without a compatible license. If you are the copyright holder, please follow the process at Wikipedia:Donating copyrighted materials to release your work under compatible licenses. For legal reasons, Wikipedia cannot host copyrighted text or images without a verified compatible license, and all copyright violations will be removed. You may use external websites or publications as a source of information, but you must write using your own words. Limited copying with context is allowed, but requires special care. Wikipedia takes copyright very seriously, and persistent violators of our copyright policy will be blocked from editing. — Diannaa 🍁 (talk) 21:22, 8 November 2026 (UTC)Reply

Information icon Hello, I'm Suðurhafsljósæta. An edit that you recently made to Propallorphan seemed to be generated using a large language model (an "AI chatbot" or other application using such technology). Text produced by these applications is not allowed on Wikipedia, and may contain factually inaccurate statements, fictitious citations, or other problems. You should instead read reliable sources and then summarize those in your own words. Your edit may have been reverted. If you want to practice editing, please use your sandbox. If you think a mistake was made, or if you have any questions, you can leave me a message on my talk page, or ask your questions at the Teahouse, a friendly place for new users. Thanks. Suðurhafsljósæta (talk) 12:57, 16 November 2026 (UTC)Reply

ArbCom 2026 Elections voter message

[edit]

Hello! Voting in the 2026 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 30 November 2026. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2026 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}} to your user talk page. MediaWiki message delivery (talk) 00:41, 17 November 2026 (UTC)Reply